Succession planning is a critical aspect of managing small, closely held businesses, as the unexpected departure of a key leader can significantly disrupt operations and challenge the business's legal...
Entering into a letter of intent for an office lease agreement? Consult our playbook for valuable key provisions, alternative language provisions, and guidance for both landlords and tenants. Download...
In the complex world of M&A transactions, transition services agreements (TSAs) serve as critical bridges between deal closing and operational independence thus creating stability during organizational...
This practice note covers key legal and regulatory issues to evaluate, questions to ask, and documents to review in medical device or diagnostic technology deals, including M&A, investments, financings...
Whether representing a healthcare institution leading a clinical trial or the pharmaceutical manufacturer (sponsor) whose medication is the focus of that trial, don’t start from scratch when negotiating and drafting agreements between the parties to support the study of the sponsor’s medication. This template, which includes guidance and drafting notes, contemplates the sponsor providing both financial support (e.g., funding for direct and indirect costs) and material support (e.g., samples of the study medication) to the institution.
READ NOW »
Related Content
Practical Guidance Updates Featuring the latest updates from your Practical Guidance account.
Experience results today with practical guidance, legal research, and data-driven insights—all in one place.Experience Lexis+
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.